as 09-16-2025 4:00pm EST
Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs. It operates in two business segments: The subscription business segment generates revenue majorly from subscription fees related to the Company's direct-to-consumer products and Other business segment is comprised of revenue from other product offerings that generally have a business-to-business relationship and a different margin profile than subscription business segment, including revenue from writing policies on behalf of third parties and revenue from other products and software solutions.
Founded: | 2000 | Country: | United States |
Employees: | N/A | City: | SEATTLE |
Market Cap: | 1.9B | IPO Year: | 2014 |
Target Price: | $55.60 | AVG Volume (30 days): | 422.1K |
Analyst Decision: | Buy | Number of Analysts: | 5 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 0.25 | EPS Growth: | N/A |
52 Week Low/High: | $31.00 - $57.90 | Next Earning Date: | 10-29-2025 |
Revenue: | $1,360,295,000 | Revenue Growth: | 13.11% |
Revenue Growth (this year): | 12.62% | Revenue Growth (next year): | 6.70% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Qureshi Fawwad | TRUP | Chief Financial Officer | Sep 2 '25 | Sell | $45.15 | 6,451 | $291,293.61 | 0 | |
Qureshi Fawwad | TRUP | Chief Financial Officer | Aug 26 '25 | Sell | $45.56 | 2,800 | $127,574.16 | 0 |
TRUP Breaking Stock News: Dive into TRUP Ticker-Specific Updates for Smart Investing
Zacks
4 days ago
GlobeNewswire
3 months ago
Argus Research
3 months ago
GlobeNewswire
3 months ago
Zacks
3 months ago
Simply Wall St.
3 months ago
Zacks
3 months ago
Argus Research
3 months ago
The information presented on this page, "TRUP Trupanion Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.